These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 12802758)

  • 1. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
    Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of health beliefs and attitudes concerning measures of antiretroviral adherence among prisoners receiving directly observed antiretroviral therapy.
    White BL; Wohl DA; Hays RD; Golin CE; Liu H; Kiziah CN; Simpson G; Kaplan AH
    AIDS Patient Care STDS; 2006 Jun; 20(6):408-17. PubMed ID: 16789854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
    Turner BJ
    J Infect Dis; 2002 May; 185 Suppl 2():S143-51. PubMed ID: 12001036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect.
    Roberts GM; Wheeler JG; Tucker NC; Hackler C; Young K; Maples HD; Darville T
    Pediatrics; 2004 Sep; 114(3):e346-53. PubMed ID: 15342896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.
    Glikman D; Walsh L; Valkenburg J; Mangat PD; Marcinak JF
    Pediatrics; 2007 May; 119(5):e1142-8. PubMed ID: 17452493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain).
    Soto Blanco JM; Pérez IR; March JC
    Int J STD AIDS; 2005 Feb; 16(2):133-8. PubMed ID: 15807941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress.
    Mitty JA; Stone VE; Sands M; Macalino G; Flanigan T
    Clin Infect Dis; 2002 Apr; 34(7):984-90. PubMed ID: 11880965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
    Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
    Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response.
    Duong M; Piroth L; Peytavin G; Forte F; Kohli E; Grappin M; Buisson M; Chavanet P; Portier H
    Clin Infect Dis; 2001 Aug; 33(3):386-92. PubMed ID: 11438909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.
    Murphy DA; Belzer M; Durako SJ; Sarr M; Wilson CM; Muenz LR;
    Arch Pediatr Adolesc Med; 2005 Aug; 159(8):764-70. PubMed ID: 16061785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
    Grossberg R; Zhang Y; Gross R
    J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
    Jayaweera DT; Kolber MA; Brill M; Tanner T; Campo R; Rodriguez A; Chu HM; Garg V
    HIV Med; 2004 Sep; 5(5):364-70. PubMed ID: 15369512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence in patients with HIV infection: a comparison of two measurement methods.
    Melbourne KM; Geletko SM; Brown SL; Willey-Lessne C; Chase S; Fisher A
    AIDS Read; 1999 Aug; 9(5):329-38. PubMed ID: 12737122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral prescribing patterns in the Texas prison system.
    Baillargeon J; Borucki MJ; Zepeda S; Jenson HB; Leach CT
    Clin Infect Dis; 2000 Dec; 31(6):1476-81. PubMed ID: 11096015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with accurate self-reported adherence to HIV antiretrovirals.
    Kimmerling M; Wagner G; Ghosh-Dastidar B
    Int J STD AIDS; 2003 Apr; 14(4):281-4. PubMed ID: 12716500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of short-term success of antiretroviral therapy in HIV infection.
    Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
    J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.